Clinical Financial Services (CFS) Launches New Service to Streamline Clinical Trial Activation
As part of its ongoing mission to provide comprehensive business and financial management solutions in support of clinical trials, Clinical Financial Services (CFS) is pleased to announce the launch of its newest offering, Site Activation Services. This new service, which includes regulatory document collection and management as well as global investigator budget and contract management, will streamline and automate the trial activation process and minimize financial risk for clinical trial sponsors, CROs, and investigative sites.
Headed by a team dedicated to managing the complex tasks required to activate investigator sites, CFS can accelerate clinical trial cycle times by maximizing the number of sites that are activated and "enrollment ready" when the enrollment phase of the trial begins.
- By pre-populating regulatory and financial disclosure documents with data from an enterprise-wide proprietary database, CFS ensures the accuracy of site and investigator information, prevents redundancy and speeds the time it takes to complete this paperwork.
- Through extensive audit capabilities, CFS ensures that financial disclosure information is compliant with 21CFR Part 54 and internal SOPs, consistent with Form FDA 1572 and aligned with aggregate spend payment data.
- With a global legal network operating in more than 60 countries, CFS supports complex contract negotiations around the world.
- By offering a technologically advanced project dashboard that is available 24/7, CFS offers unprecedented visibility into the status of every trial start-up document.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
